Leo Wealth LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Sell
15,866
-562
-3% -$86.1K 0.18% 104
2025
Q4
$2.26M Buy
16,428
+3,148
+24% +$412K 0.16% 107
2025
Q3
$1.7M Sell
13,280
-3,100
-19% -$378K 0.22% 85
2025
Q2
$1.98M Buy
16,380
+2,210
+16% +$249K 0.15% 122
2025
Q1
$1.58M Buy
14,170
+2,297
+19% +$245K 0.23% 88
2024
Q4
$1.16M Sell
11,873
-2,066
-15% -$220K 0.1% 138
2024
Q3
$1.6M Buy
13,939
+1,047
+8% +$119K 0.15% 111
2024
Q2
$1.37M Buy
12,892
+3,488
+37% +$350K 0.14% 115
2024
Q1
$907K Sell
9,404
-578
-6% -$59.3K 0.09% 156
2023
Q4
$1.01M Buy
+9,982
New +$964K 0.1% 142

Other funds holding NVS

Leo Wealth LLC's NVS Position: Q1 2026 in Review

Leo Wealth LLC reduced its Novartis (NVS) stake by 3.4% in Q1 2026, selling an estimated $86.1K and leaving 15,866 shares worth $2.42M. The position accounts for 0.18% of the portfolio, ranked #104.

Leo Wealth LLC first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. 1,599 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Leo Wealth LLC held 15,866 shares of Novartis worth $2.42M as of Q1 2026.
  • Leo Wealth LLC sold 562 Novartis shares in Q1 2026, an estimated $86.1K.
  • Novartis made up 0.18% of Leo Wealth LLC's portfolio in Q1 2026, its #104 holding.
  • Leo Wealth LLC first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
  • 1,599 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.